Table 3.
Previous reports regarding clinicopathologic features and MLN involvement in ovarian cancer
| FIGO stage | Histologic type | Pathologic tumor grade | Depth of bowel infiltration | PLN | LALN | |
|---|---|---|---|---|---|---|
| O’Hanlan KA et al.5 Gynecol Oncol. (1995) | N/S | N/S | No (p = 0.14) | No (p = 0.08) | N/S | N/S |
| Salani R et al.6 Ann Surg Oncol. (2007) | N/S | No (p = NS) | N/S | Yes (p < 0.01) | N/S | No (p = 0.025) |
| Baiocchi G et al.7 J Surg Oncol. (2011) | N/S | No (p = 0.068) | No (p = 0.73) | Yes (p = 0.036) | No (p = 0.11) | Yes (p = 0.002) |
| Gouy S et al.8 Eur J Surg Oncol. (2012) | N/S | No | No | No | No | No |
| Gallotta V et al.9 Ann Surg Oncol. (2014) | N/S | No (p = 0.49) | No (p = 0.37) | Yes (p = 0.026) | No (p = 0.72) | No (p = 0.71) |
| Berretta R et al.10 Arch Gynecol Obstet. (2018) | N/S | N/S | N/S | N/S | Yes (p = 0.012) | Yes (p = 0.006) |
| Tanaka K et al.11 Ann Surg Oncol. (2021) | No (p = 0.236) | No (p = 0.999) | N/S | N/S | N/S | N/S |
| Our study (2023) | No (p = 0.984) | No (p = 0.460) | No (p = 0.706) | No (p = 0.133) | No (p = 0.421) | No (p = 0.067) |
MLN, mesenteric lymph node; FIGO, International Federation of Gynecology and Obstetrics; PLN, pelvic lymph node; LALN, lombo-aortic lymph node; N/S, not specified; NS, not significant